← Latest papers
🧬 biology

50µm ex vivo MRI reveals distant layer-specific hippocampal atrophy in early Alzheimer's disease

Using ultra-high-resolution 50µm ex vivo MRI, this study reveals that early Alzheimer's disease (Braak stage II) is characterized by distant, layer-specific atrophy in the anterior CA1 and subiculum regions, which is strongly driven by tau pathology in upstream entorhinal areas rather than local tau burden.

Original authors: Yasmine Salman, Sandra O. Tomé, Nicolas Joudiou, Amanda Annettesdotter, Pulkit Khandelwal, Tevi M. Lawson, Catherine Behets, Benoît Lengelé, Dietmar R. Thal, Paul A. Yushkevich, Bernard Gallez, Laura
Published 2026-09-01
📖 5 min read🧠 Deep dive

Original authors: Yasmine Salman, Sandra O. Tomé, Nicolas Joudiou, Amanda Annettesdotter, Pulkit Khandelwal, Tevi M. Lawson, Catherine Behets, Benoît Lengelé, Dietmar R. Thal, Paul A. Yushkevich, Bernard Gallez, Laura EM Wisse, Bernard J Hanseeuw

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Alzheimer's disease is a slow, relentless fading of the mind, driven by the accumulation of toxic proteins that clog and destroy brain cells. Among these culprits, a protein called tau is particularly destructive, forming twisted knots inside neurons that eventually kill them. For decades, scientists have known that this tau damage follows a predictable path, starting in a deep, seahorse-shaped region of the brain called the hippocampus, which is essential for memory. The earliest signs of this damage appear in a specific layer of the hippocampus, but for a long time, the tools available to study the living human brain were too blunt to see these tiny, initial changes. Standard brain scans could show that the hippocampus was shrinking in later stages of the disease, but they could not reveal exactly which microscopic layers were dying first, or how the damage began to spread from one area to another. Without this level of detail, it has been difficult to understand the very first steps of the disease or to find ways to stop it before significant memory loss occurs.

To solve this puzzle, a team of researchers turned to a different approach: they looked at brains after death with a level of detail never before achieved in a living person. Using a powerful magnetic resonance imaging scanner, they examined 19 human brains that had been preserved and scanned at an incredibly fine resolution of 50 micrometers. To put this scale in perspective, a single human hair is roughly 50 to 70 in 'AU' wide; the researchers were able to see structures as small as the width of a hair inside the brain. This technique allowed them to map the brain's internal architecture with a precision that matches the finest biological maps, revealing layers of cells that are usually invisible to standard medical imaging. They focused specifically on brains that were in the very earliest stages of tau accumulation, known as Braak stages I and II, where the disease has just begun to take hold but before widespread dementia sets in.

The researchers discovered that even at these earliest stages, the brain was already showing signs of thinning, but not where one might expect. While the initial tau knots formed in the outer layers of the memory center, the most significant shrinking was happening in a different, connected area: the front part of the hippocampus's main output layer. Specifically, the layer of cells responsible for sending signals out of the hippocampus, known as the pyramidal cell layer, was noticeably thinner in brains with slightly more tau than in those with the absolute minimum. This thinning was not random; it was tightly linked to the amount of tau found in the starting point of the disease, the entorhinal cortex. The data suggests that the damage is not just happening where the toxic knots are sitting, but is also affecting the cells that receive signals from that area. It is as if the toxic protein in one neighborhood is causing the houses in the next neighborhood over to crumble, even though the toxic protein itself hasn't fully arrived there yet.

This finding points to a specific mechanism of how Alzheimer's might spread. The researchers found that the thinning in the hippocampus was more strongly related to the tau burden in the upstream starting region than to the tau found locally in the hippocampus itself. This supports the idea that the disease travels along the brain's wiring, damaging cells that are connected to the infected area, a process that happens before the toxic knots even form in the new location. The study also revealed that this early damage is not uniform; it hits the front part of the hippocampus harder than the back, and it affects specific layers of cells while leaving others relatively untouched. Furthermore, the researchers found that another type of protein damage, involving a protein called TDP-43, seemed to make the tau-related thinning worse, particularly in the front part of the hippocampus. This suggests that when multiple types of protein damage occur together, they may accelerate the loss of brain tissue.

By using this ultra-high-resolution imaging, the team was able to see the brain's internal structure in a way that was previously impossible, distinguishing between layers of cells that standard scans blur together. They could clearly see the distinct bands of cells in the dentate gyrus and the precise boundaries between different sections of the hippocampus. This clarity allowed them to pinpoint exactly where the damage was starting. The study confirms that the earliest structural changes in Alzheimer's disease are detectable and specific, occurring in the front part of the hippocampus's output layer and driven by the spread of tau from the entorhinal cortex. While the sample size was small and the findings are based on post-mortem tissue, the results provide a clear, high-definition map of the disease's earliest footprint. This detailed view offers a new target for future research, suggesting that to stop Alzheimer's, we may need to intervene before the toxic proteins even reach the hippocampus, protecting the cells that are most vulnerable to the spread of damage from the very beginning.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →